Pre-pregnancy, it is important to optimise control of your asthma. During pregnancy you should be closely monitored so that appropriate changes to treatment can be quickly implemented in response to any changed symptoms. In general, asthma inhalers are believed to be safe in pregnancy and the risk of harm to the foetus is much greater from having undertreated and poorly controlled asthma. Roughly one third of women find that their asthma improves during pregnancy, one third find that it stays the same, and the final third find that it worsens.
Q. Do I need to go through all the patient records on the PMR system for the last 6 months and identify any patients who have been prescribed more than 6 short acting bronchodilator inhalers without a corticosteroid inhaler within a 6-month period to meet this criterion?
No. Contractors do not need to have reviewed 6 months of patient records to meet this criterion. On the day of the review the pharmacy must be able to show evidence of the asthma patients, for whom more than 6 short acting bronchodilator inhalers were dispensed without any corticosteroid inhaler within a 6-month period, that have been referred to an appropriate health care professional for an asthma review. There must, therefore, be a process in place, to identify these asthma patients. This process can be incorporated into daily practice (PSNC has suggested a process for referring patients for an asthma review).